Jaime E Sidani1, Jason B Colditz2, Erica L Barrett2, Ariel Shensa2, Kar-Hai Chu2, A Everette James3, Brian A Primack4. 1. Center for Research on Media, Technology, and Health, University of Pittsburgh, 230 McKee Place, Suite 600, Pittsburgh, PA 15213, United States. Electronic address: Jaime.sidani@pitt.edu. 2. Center for Research on Media, Technology, and Health, University of Pittsburgh, 230 McKee Place, Suite 600, Pittsburgh, PA 15213, United States. 3. Health Policy Institute, University of Pittsburgh, 3550 Terrace Street, Pittsburgh, PA 15261, United States. 4. College of Education and Health Professions, University of Arkansas, 324 Graduate Education Building, Fayetteville, AR, 72701, United States.
Abstract
BACKGROUND: JUUL-a novel electronic nicotine delivery system (ENDS)-comprises most of the ENDS market share. Additionally, JUUL has a high nicotine content and utilizes a patented nicotine salt formulation aimed to speed absorption. Many JUUL users are not aware of the nicotine content and therefore may not be expecting acute nicotine effects or potential for dependence. This study sought to analyze Twitter messages ("tweets") regarding nicotine, symptoms of dependence, and withdrawal related to JUUL use. METHODS: Data were collected from Twitter's Filtered Streams interface 4/11-6/16/2018 by retrieving tweets matching the terms "juul," "juuls," and "juuling" that also used words consistent with nicotine effects, symptoms of dependence, and withdrawal. A random 5% subsample (n = 1986) was coded by 2 independent coders. Cohen's κ for inter-rater reliability ranged 0.62-1.00 for all coded variables. Tweets were assessed using a qualitative content analysis approach. RESULTS: A total of 335 tweets mentioned dependence-related themes, including use upon waking and compulsion to use. A total of 189 tweets mentioned themes related to nicotine, with almost 15% of these tweets describing physical effects. Additionally, 42 tweets mentioned themes related to quitting JUUL and/or withdrawal from JUUL. DISCUSSION: This qualitative analysis suggests that users of JUUL are experiencing symptoms of nicotine exposure and dependence. Considering the high nicotine content of JUUL and the rising popularity among young people, more research around initiation of and dependence on JUUL, as well as the impact of recent FDA policy changes, should be conducted.
BACKGROUND: JUUL-a novel electronic nicotine delivery system (ENDS)-comprises most of the ENDS market share. Additionally, JUUL has a high nicotine content and utilizes a patented nicotine salt formulation aimed to speed absorption. Many JUUL users are not aware of the nicotine content and therefore may not be expecting acute nicotine effects or potential for dependence. This study sought to analyze Twitter messages ("tweets") regarding nicotine, symptoms of dependence, and withdrawal related to JUUL use. METHODS: Data were collected from Twitter's Filtered Streams interface 4/11-6/16/2018 by retrieving tweets matching the terms "juul," "juuls," and "juuling" that also used words consistent with nicotine effects, symptoms of dependence, and withdrawal. A random 5% subsample (n = 1986) was coded by 2 independent coders. Cohen's κ for inter-rater reliability ranged 0.62-1.00 for all coded variables. Tweets were assessed using a qualitative content analysis approach. RESULTS: A total of 335 tweets mentioned dependence-related themes, including use upon waking and compulsion to use. A total of 189 tweets mentioned themes related to nicotine, with almost 15% of these tweets describing physical effects. Additionally, 42 tweets mentioned themes related to quitting JUUL and/or withdrawal from JUUL. DISCUSSION: This qualitative analysis suggests that users of JUUL are experiencing symptoms of nicotine exposure and dependence. Considering the high nicotine content of JUUL and the rising popularity among young people, more research around initiation of and dependence on JUUL, as well as the impact of recent FDA policy changes, should be conducted.
Authors: Jessica L King; David Reboussin; Jennifer Cornacchione Ross; Kimberly D Wiseman; Kimberly G Wagoner; Erin L Sutfin Journal: J Adolesc Health Date: 2018-08-13 Impact factor: 5.012
Authors: Jeffrey G Willett; Morgane Bennett; Elizabeth C Hair; Haijuan Xiao; Marisa S Greenberg; Emily Harvey; Jennifer Cantrell; Donna Vallone Journal: Tob Control Date: 2018-04-18 Impact factor: 7.552
Authors: Kar-Hai Chu; Jason B Colditz; Brian A Primack; Ariel Shensa; Jon-Patrick Allem; Elizabeth Miller; Jennifer B Unger; Tess Boley Cruz Journal: J Adolesc Health Date: 2018-11 Impact factor: 5.012
Authors: Natalie Berry; Fiona Lobban; Maksim Belousov; Richard Emsley; Goran Nenadic; Sandra Bucci Journal: J Med Internet Res Date: 2017-04-05 Impact factor: 5.428
Authors: Terry Gordon; Emma Karey; Meghan E Rebuli; Yael-Natalie H Escobar; Ilona Jaspers; Lung Chi Chen Journal: Annu Rev Pharmacol Toxicol Date: 2021-09-23 Impact factor: 16.459
Authors: Alex M Russell; Jason B Colditz; Adam E Barry; Robert E Davis; Shelby Shields; Juanybeth M Ortega; Brian Primack Journal: Nicotine Tob Res Date: 2022-07-13 Impact factor: 5.825
Authors: Kelsey A Simpson; Afton Kechter; Sara J Schiff; Jessica L Braymiller; Naosuke Yamaguchi; Rachel Carmen Ceasar; Ricky N Bluthenthal; Jessica L Barrington-Trimis Journal: BMC Public Health Date: 2021-05-20 Impact factor: 3.295
Authors: Jaime E Sidani; Beth L Hoffman; Jason B Colditz; Eleanna Melcher; Sanya Bathla Taneja; Ariel Shensa; Brian Primack; Esa Davis; Kar-Hai Chu Journal: Subst Use Misuse Date: 2022-01-22 Impact factor: 2.362